European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Urological Infections

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
  • 2024
  • 2025
  • 2023
  • 2022
  • 2021
  • 2020
2020
  • 2024
  • 2025
  • 2023
  • 2022
  • 2021
  • 2020
  • No elements found. Consider changing the search query.
  • List is empty.

For the 2020 Urological Infections Guidelines, new and relevant evidence was identified, collated and appraised through a structured assessment of the literature. Broad and comprehensive literature searches, covering these sections were performed. Databases searched included Medline, EMBASE, and the Cochrane Libraries. The number of unique records identified, retrieved and screened for relevance for each section were:

  • 3.4 Uncomplicated cystitis: 694 abstracts; 78 full texts; all excluded.
  • 3.6 Uncomplicated pyelonephritis: 1,006 abstracts; 48 full texts; 13 included.
  • 3.7 Complicated urinary tract infections: 1,331 abstracts; 13 included
  • 3.10 Urethritis: 488 abstracts; 71 full texts; 30 included.

Specific changes include:

  • 3.4.4 Disease management of uncomplicated cystitis
    On March 11, 2019 the European Commission implemented stringent regulatory conditions regarding the use of fluoroquinolones due to their disabling and potentially long-lasting side effects. This legally binding decision is applicable in all EU countries. National authorities have been urged to enforce this ruling and to take all appropriate measures to promote the correct use of this class of antibiotics. In uncomplicated cystitis a fluoroquinolone should only be used when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.
  • Table 4: Suggested regimens for empirical parenteral antimicrobial therapy in uncomplicated pyelonephritis has been updated to include last-line alternatives.
  • 3.10.6 Summary of evidence and recommendations for the diagnostic evaluation and antimicrobial treatment of urethritis have been updated to reflect the evidence.
  • Table 8: Suggested regimens for antimicrobial therapy for urethritis has been updated to reflect the evidence.
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer